Biosimilar Retacrit(®) (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study

BACKGROUND: Symptomatic anemia is a frequent and severe complication of chemotherapy that is commonly treated with erythropoiesis-stimulating agents. The primary objective of this study was to assess the change in hemoglobin levels in patients with chemotherapy-induced anemia (CIA) following treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Losem, Christoph, Koenigsmann, Michael, Rudolph, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338968/
https://www.ncbi.nlm.nih.gov/pubmed/28280364
http://dx.doi.org/10.2147/OTT.S122427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338968/
https://www.ncbi.nlm.nih.gov/pubmed/28280364
http://dx.doi.org/10.2147/OTT.S122427

Ejemplares similares